drugset / Trial / NCT01318733
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A long-term, open-label, non-comparative safety and efficacy study of CD07805/47 gel 0.5% once daily in subjects with moderate to severe facial erythema associated with rosacea.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.5 % | Topical |